| Literature DB >> 25946043 |
Bita Hashemi1, Anne Bassett2, David Chitayat1,3, Karen Chong3, Mark Feldman4, Janine Flanagan5, Sharan Goobie6, Anne Kawamura7, Chelsea Lowther2, Chitra Prasad6, Victoria Siu6, Joyce So8,9,10, Sharon Tung11, Marsha Speevak12, Dimitri J Stavropoulos10, Melissa T Carter1.
Abstract
Microdeletion of the BP1-BP2 region at 15q11.2 is a recurrent copy number variant (CNV) frequently found in patients undergoing chromosomal microarray (CMA). Genetic counselling regarding this CNV is challenging due to the wide range of phenotypic presentation in reported patients and lack of general population-based data. As one of the most common reasons for CMA is childhood developmental delay, clinicians need to be cognizant of the inherent ascertainment bias in the literature. We performed a detailed medical record review for 55 patients with this 15q11.2 microdeletion and report the clinical features of the 35 patients for whom information was available. We compared our results to the recent report by Cafferkey et al. in this journal. Our conclusion is that the phenotypic spectrum is too broad and non-specific to constitute a bona fide "syndrome" and that further research must be done to delineate the contribution of this CNV to phenotype.Entities:
Keywords: 15q11.2; array CGH; autism; developmental delay; epilepsy; microdeletion
Mesh:
Year: 2015 PMID: 25946043 DOI: 10.1002/ajmg.a.37134
Source DB: PubMed Journal: Am J Med Genet A ISSN: 1552-4825 Impact factor: 2.802